Virpax Pharmaceuticals Stock Price on December 3, 2024
| VRPX Stock | USD 0.31 0.01 3.13% |
If you're considering investing in Virpax Stock, it is important to understand the factors that can impact its price. As of today, the current price of Virpax Pharmaceuticals stands at 0.31, as last reported on the 11th of December 2024, with the highest price reaching 0.31 and the lowest price hitting 0.31 during the day. Virpax Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.17, which indicates the firm had a -0.17% return per unit of risk over the last 3 months. Virpax Pharmaceuticals exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Virpax Pharmaceuticals' Coefficient Of Variation of (640.28), risk adjusted performance of (0.10), and Variance of 55.2 to confirm the risk estimate we provide.
At this time, Virpax Pharmaceuticals' Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 12.7 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 1.8 M in 2024. . At this time, Virpax Pharmaceuticals' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.01 in 2024, whereas Price Earnings Ratio is likely to drop (0.26) in 2024. Virpax Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Virpax |
Sharpe Ratio = -0.1744
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VRPX |
Estimated Market Risk
| 7.54 actual daily | 67 67% of assets are less volatile |
Expected Return
| -1.32 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.17 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Virpax Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Virpax Pharmaceuticals by adding Virpax Pharmaceuticals to a well-diversified portfolio.
Price Book 0.4844 | Book Value (0.98) | Enterprise Value 2.7 M | Enterprise Value Ebitda (0.05) | Shares Float 4.6 M |
Related Headline
Valneva SE Headline on 3rd of December 2024
Valnevas Chikungunya Shot Shows Strong, Long-Lasting Antibod... by benzinga.com
Valneva reports long-lasting antibody persistence in its chikungunya vaccine three years post-dose, supporting its global approvals and expansion efforts.
Virpax Pharmaceuticals Valuation on December 3, 2024
It is possible to determine the worth of Virpax Pharmaceuticals on a given historical date. On December 3, 2024 Virpax was worth 0.44 at the beginning of the trading date compared to the closed value of 0.44. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Virpax Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Virpax Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Virpax Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Virpax Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 0.48 | 0.48 | 0.44 | 0.45 | 885,574 | |
12/03/2024 | 0.44 | 0.45 | 0.43 | 0.44 | 620,300 |
| 0.40 | 0.42 | 0.39 | 0.41 | 1,027,099 |
| Backtest Virpax Pharmaceuticals | | | Virpax Pharmaceuticals History | | | Virpax Pharmaceuticals Valuation | Previous | Next |
Virpax Pharmaceuticals Trading Date Momentum on December 3, 2024
| On December 04 2024 Virpax Pharmaceuticals was traded for 0.41 at the closing time. The top price for the day was 0.42 and the lowest listed price was 0.39 . The trading volume for the day was 1 M. The trading history from December 4, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 6.82% . The trading price change against the current closing price is 27.27% . |
Virpax Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Virpax Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Virpax Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Virpax financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Virpax Pharmaceuticals Stock history
Virpax Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Virpax is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Virpax Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Virpax Pharmaceuticals stock prices may prove useful in developing a viable investing in Virpax Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.2 M | 1.3 M | |
| Net Loss | -10.9 M | -10.3 M |
Virpax Pharmaceuticals Stock Technical Analysis
Virpax Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Virpax Pharmaceuticals Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Virpax Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Virpax Pharmaceuticals December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Virpax Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Virpax Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Virpax Pharmaceuticals stock market strength indicators, traders can identify Virpax Pharmaceuticals entry and exit signals to maximize returns
Virpax Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Virpax Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Virpax Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Virpax to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (1.35) | |||
| Total Risk Alpha | (2.35) | |||
| Treynor Ratio | (0.73) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Virpax Stock Analysis
When running Virpax Pharmaceuticals' price analysis, check to measure Virpax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virpax Pharmaceuticals is operating at the current time. Most of Virpax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Virpax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virpax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Virpax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.